Ceritinib

Ceritinib, marketed under the brand name Zykadia, is a type of targeted cancer therapy that is used for the treatment of ALK (anaplastic lymphoma kinase)-positive advanced non-small cell lung cancer in adults. This highly effective targeted cancer therapy works by binding to ALK proteins, blocking their activity from producing cancer cells. This type of targeted…